Search

Your search keyword '"Voest, Emile"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Voest, Emile" Remove constraint Author: "Voest, Emile" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
291 results on '"Voest, Emile"'

Search Results

1. Base editing screens define the genetic landscape of cancer drug resistance mechanisms

2. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma

3. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

6. Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)

7. A pan-cancer analysis of the microbiome in metastatic cancer

8. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics

9. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

10. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

11. Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity

14. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

16. Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

19. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

22. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

24. Pan-cancer whole-genome analyses of metastatic solid tumours

25. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

35. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

36. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

37. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

38. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

39. Long‐term expanding human airway organoids for disease modeling

40. Precision cancer medicine: Concepts, current practice, and future developments.

43. Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma.

44. Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens.

45. Facilitating a culture of responsible and effective sharing of cancer genome data

46. A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

Catalog

Books, media, physical & digital resources